In multiple sclerosis anxiety, not depression, is related to gender

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Multiple Sclerosis

• Publication date

  2016-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/1352458515588582PMID 26041798
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sex differences in anxiety and depression clinical perspectives.

  2014cited by this paper
• New data identify an increasing sex ratio of multiple sclerosis in Sweden

  2014cited by this paper
• Relationship between disease-modifying therapy and depression in multiple sclerosis.

  2013cited by this paper
• A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register

  2012cited by this paper
• Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease.

  2011cited by this paper
• Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

  2010cited by this paper
• Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients

  2010cited by this paper
• Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County, Norway

  2009cited by this paper
• Injection anxiety remains a long-term barrier to medication adherence in multiple sclerosis.

  2009cited by this paper
• Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients

  2009cited by this paper
• Gender differences in depression and anxiety across the adult lifespan: the role of psychosocial mediators

  2008cited by this paper
• Psychological aspects of multiple sclerosis.

  2008cited by this paper
• Astrocytes—Friends or foes in multiple sclerosis?

  2007cited by this paper
• Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression

  2007cited by this paper
• Anxiety disorders and their clinical correlates in multiple sclerosis patients

  2007cited by this paper
• Prevalence and incidence of depressive disorder: the Baltimore ECA follow‐up, 1981–2004

  2007cited by this paper
• Longitudinal course of depression symptoms in multiple sclerosis

  2006cited by this paper
• Sex ratio of multiple sclerosis in Canada: a longitudinal study.

  2006cited by this paper
• Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy

  2005cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• US FDA-Approved Disease-Modifying Treatments for Multiple Sclerosis

  2005cited by this paper
• Cytokines and major depression.

  2005cited by this paper
• Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

  2005cited by this paper
• Structural brain abnormalities in multiple sclerosis patients with major depression

  2004cited by this paper
• Major depression in multiple sclerosis

  2003cited by this paper
• Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.

  2002cited by this paper
• Depression in Multiple Sclerosis Associated with Interferon Beta-1a (Rebif)

  2002cited by this paper
• Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis

  2001cited by this paper
• Normative data for the HADS from a large non-clinical sample.

  2001cited by this paper
• The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis

  1999cited by this paper
• Gender differences in anxiety disorders and anxiety symptoms in adolescents.

  1998cited by this paper
• Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis

  1997cited by this paper
• Depression and multiple sclerosis

  1996cited by this paper
• Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

  1994cited by this paper
• Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

  1993cited by this paper
• Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

  1993cited by this paper
• A prospective study of depression and immune dysregulation in multiple sclerosis.

  1992cited by this paper
• Women and Depression: A Lifespan Perspective

  1987cited by this paper
• New diagnostic criteria for multiple sclerosis: Guidelines for research protocols

  1983cited by this paper
• The Hospital Anxiety and Depression Scale

  1983cited by this paper
• [Psychological aspects of multiple sclerosis].

  1954cited by this paper
• BRAIN IMAGING: Brain MRI lesions and atrophy are related to depression in multiple sclerosis

  year unknowncited by this paper

• Sex differences in the rate and factors for elevated depressive symptoms in multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis.

  2026cites this paper
• Comparative analysis of depression and anxiety in Psoriasis and Multiple Sclerosis: The role of body image and illness personification as serial mediators.

  2025cites this paper
• A medicine called art: a narrative analysis of women with multiple sclerosis' perceptions of art classes in Iran.

  2025cites this paper
• A Review of Sex Differences in Neurodegeneration and Psychological Comorbidities in Multiple Sclerosis and Related Disorders

  2025influential citation
• Mood Associated With Health- and Social Care-Related Quality of Life in Patients With Advanced Multiple Sclerosis.

  2024cites this paper
• Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis

  2024cites this paper
• Risk of depression and anxiety in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea

  2024influential citation
• Self‐reported restrictions in different life domains and associated factors among people with multiple sclerosis in Sweden

  2023cites this paper
• Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort

  2023cites this paper
• Barriers to quality of life in patients with multiple sclerosis: a qualitative study

  2022cites this paper
• Clinical correlates of state and trait anxiety in multiple sclerosis.

  2022cites this paper
• The Effectiveness of Lazarus Multimodal Approach on Psychological Distress, Working Memory, and Anxiety in Patients With Multiple Sclerosis

  2022cites this paper
• The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools

  2022cites this paper
• A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.

  2022cites this paper
• Differences in symptoms of depression between females and males with relapsing-remitting multiple sclerosis.

  2021cites this paper
• Comparison of the Effect of Lazarus Multimodal Approach and Cognitive-Behavioral Therapy on Psychological Distress, Working Memory, and Anxiety in Patients with Multiple Sclerosis

  2021cites this paper
• The emotional disorders associated with multiple sclerosis.

  2021cites this paper
• Using the multiple sclerosis resiliency scale to identify psychological distress in persons with multiple sclerosis.

  2021cites this paper
• Disability and its association with psychological factors in multiple sclerosis patients.

  2021cites this paper
• Depressive Symptoms and Suicidal Ideation in Progressive Multiple Sclerosis Compared to Relapsing-Remitting Multiple Sclerosis: Results from a Cross-Sectional Survey.

  2020cites this paper
• Health-related quality of life after cardiac arrest

  2020cites this paper
• Effects of long-term administration of Multi-Strain Probiotic on circulating levels of BDNF, NGF, IL-6 and mental health in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial

  2020cites this paper
• A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications

  2020cites this paper
• Predictors of clinically significant anxiety in people with multiple sclerosis: A one-year follow-up study.

  2020cites this paper
• Transdiagnostic treatment of emotional disorders for women with multiple sclerosis: a randomized controlled trial

  2020cites this paper
• Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable Accelerometers

  2020cites this paper
• “Taming the Beast”: Exploring the Lived Experience of Relapsing Remitting Multiple Sclerosis Using a Life History Approach

  2019cites this paper
• Relationship between social cognition and fatigue, depressive symptoms, and anxiety in multiple sclerosis.

  2019cites this paper
• Depression and Suicidality in Multiple Sclerosis: Red Flags, Management Strategies, and Ethical Considerations

  2019cites this paper
• Caring for Women with Multiple Sclerosis Across the Lifespan

  2018cites this paper
• Diagnostic and Clinical Utility of the GAD-2 for Screening Anxiety Symptoms in Individuals With Multiple Sclerosis.

  2018cites this paper
• The relationship between depression, anxiety and cognition and its paradoxical impact on falls in multiple sclerosis patients.

  2018cites this paper
• The prevalence of anxiety and associated factors in persons with multiple sclerosis.

  2018cites this paper
• Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder.

  2018cites this paper
• Interhermispheric inhibition predicts anxiety levels in multiple sclerosis: A corticospinal excitability study.

  2018cites this paper
• Multiple Sclerosis, Gender, and Disorders of Behavior

  2017cites this paper
• Signes et symptômes de la sclérose en plaques

  2017cites this paper
• A systematic review of anxiety amongst people with Multiple Sclerosis.

  2016cites this paper
• Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.

  2016cites this paper
• Characterizing the phenotype of multiple sclerosis–associated depression in comparison with idiopathic major depression

  2016cites this paper
• Psychological profiles of patients with multiple sclerosis based on Hobfoll’s conservation of resources theory

  2016cites this paper
• Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder

  2016cites this paper
• Multiple sclerosis in men: management considerations

  2016cites this paper
• Anxiety in Multiple Sclerosis: psychometric properties of the State‐Trait Anxiety Inventory

  2016cites this paper
• The Clinical and Epidemiological Spectrum of Multiple Sclerosis in Quito, Ecuador

  2016cites this paper
• NEUROLOGY AND PRECLINICAL NEUROLOGICAL STUDIES - REVIEW ARTICLE

  year unknowncites this paper